August 18, 2022 Researchers find that treatment with folate, a methyl donor, can modify the epigenome of glioblastomas.
Neuroscience biweekly vol. 49, 28th December — 12th January A goldfish has successfully driven a robotic car in new research…
Glioblastoma (GBM) is a brain tumor with a poor prognosis and therapies to date have failed to improve survival.
A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent…
A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent…
A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent…
A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent…
The researchers showed for the first time that the DNA methylome of these brain tumors can be reprogrammed.
Credit: Pixabay/CC0 Public Domain A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for…
A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent…
Vanderbilt University Medical Center A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy…